Author Question: Over evolutionary time, many cave-dwelling organisms have lost their eyes. Tapew (Read 1331 times)

hummingbird

  • Sr. Member
  • ****
  • Posts: 324
Over evolutionary time, many cave-dwelling organisms have lost their eyes. Tapeworms have lost their digestive systems. Whales have lost their hind limbs. How can natural selection account for these losses?
A) Natural selection cannot account for losses, only for innovations.
B) Natural selection accounts for these losses by the principle of use and disuse.
C) Under particular circumstances that persisted for long periods, each of these structures presented greater costs than benefits.
D) The ancestors of these organisms experienced harmful mutations that forced them to find new habitats that these species had not previously used.




Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Alcohol acts as a diuretic. Eight ounces of water is needed to metabolize just 1 ounce of alcohol.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

All adults should have their cholesterol levels checked once every 5 years. During 2009–2010, 69.4% of Americans age 20 and older reported having their cholesterol checked within the last five years.

Did you know?

Drug abusers experience the following scenario: The pleasure given by their drug (or drugs) of choice is so strong that it is difficult to eradicate even after years of staying away from the substances involved. Certain triggers may cause a drug abuser to relapse. Research shows that long-term drug abuse results in significant changes in brain function that persist long after an individual stops using drugs. It is most important to realize that the same is true of not just illegal substances but alcohol and tobacco as well.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library